EmbPred30: Assessing 30-days Readmission for Diabetic Patients using Categorical Embeddings

Diabetes is a disease-causing high level of blood sugar. In type 1 Diabetes, body doesn't produce insulin, but if injected from external sources, will use it and in type 2, the body doesn't produce as well as use insulin. It is estimated that 30.3 million people of all ages in the US are suffering from Diabetes as of 2015, out of which 7.2 million are unaware[1]. As of 2016, it is ranked seventh in the list of global causes of mortality. Diabetes can be an underlying cause for many cardiovascular diseases, retinopathy, and nephropathy leading to frequent readmission in the hospital. The Centers for Medicare and Medicaid Services(CMS) labeled a 30-day readmission rate as a measure of healthcare quality offered by the hospital in order to provide the best inpatient care and improve the healthcare quality. Hospitals with high readmission rates will be penalized as per the Patient Protection and Affordable Care Act(ACA) of 2010[2]. During the recent studies[19], it was observed that a 30-day readmission rate for patients with Diabetes ranges between 14.4%-22.7%,